A clinical study of STUP-002 for Parkinson's disease
Latest Information Update: 30 Dec 2022
At a glance
- Drugs STUP-002 (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
Most Recent Events
- 30 Dec 2022 New trial record
- 27 Dec 2022 According to a Stand Up Therapeutics media release, the company expects to start this study in the second half of next year 2023.